MRNA reported a Covid-19 vaccine agreement with the U.S. government. The U.S. government secured 100 million doses of Moderna’s vaccine candidate, MRNA-1273, and will pay up to $ 1.525 billion. Moderna shares climbed 11.3% to $ 76.75 in the after-hours trading session. Monitor behavior when the Market opens
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.